"10.1371_journal.pone.0074249","plos one","2013-09-18T00:00:00Z","Francesca Di Giallonardo; Osvaldo Zagordi; Yannick Duport; Christine Leemann; Beda Joos; Marzanna Künzli-Gontarczyk; Rémy Bruggmann; Niko Beerenwinkel; Huldrych F Günthard; Karin J Metzner","Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Biosystems Sciences and Engineering, ETH Zurich, Basel, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland; Functional Genomics Center Zurich (FGCZ), University of Zurich, ETH Zurich, Zurich, Switzerland; SIB Swiss Institute of Bioinformatics, Basel, Switzerland","Conceived and designed the experiments: FDG NB HFG KJM. Performed the experiments: FDG YD CL MK. Analyzed the data: FDG OZ BJ RB KJM. Wrote the paper: FDG OZ KJM.","HFG has been an adviser and/or consultant for the following companies: GlaxoSmithKline, Abbott, Gilead, Novartis, Boehringer Ingelheim, Roche, Tibotec, Pfizer and Bristol-Myers Squibb, and has received unrestricted research and educational grants from Roche, Abbott, Bristol-Myers Squibb, Gilead, Astra-Zeneca, GlaxoSmithKline, and Merck Sharp & Dohme (all money went to institution). KJM received travel grants and honoraria from Gilead Sciences, Roche Diagnostics, Tibotec, Bristol-Myers Squibb, and Abbott; the University of Zurich has received research grants from Gilead, Roche, and Merck Sharp & Dohme for studies that KJM serves as principal investigator and advisory board honoraria from Gilead Sciences. All other authors declare no conflict of interest. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Francesca Di Giallonardo","FDG",10,TRUE,4,4,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
